Authors:
Lein, M
Jung, K
Elgeti, U
Brux, B
Sinha, P
Schnorr, D
Loening, SA
Citation: M. Lein et al., Ratio of alpha1-antichymotrypsin - Prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis, ANTICANC R, 20(6D), 2000, pp. 4997-5001
Authors:
Stephan, C
Jung, K
Brux, B
Lein, M
Sinha, P
Schnorr, D
Loening, SA
Citation: C. Stephan et al., ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: Proof of new complex forming of PSA after release into circulation, UROLOGY, 55(4), 2000, pp. 560-563
Authors:
Fritsche, L
Budde, K
Rogalla, P
Turk, I
Neumayer, HH
Loening, SA
Citation: L. Fritsche et al., Re: Successful living related kidney transplantation despite renal angiomyolipoma in situ - L. Fritsche, K. Budde, P. Rogalla, I. Turk, H.-H. Neumayer and S. A. Loening - J-Urol., 162 : 480-481, 1999 - Reply by authors, J UROL, 163(3), 2000, pp. 924-924
Authors:
Lein, M
Jung, K
Laube, C
Hubner, T
Winkelmann, B
Stephan, C
Hauptmann, S
Rudolph, B
Schnorr, D
Loening, SA
Citation: M. Lein et al., Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma, INT J CANC, 85(6), 2000, pp. 801-804
Authors:
Jung, K
Brux, B
Lein, M
Rudolph, B
Kristiansen, G
Hauptmann, S
Schnorr, D
Loening, SA
Sinha, P
Citation: K. Jung et al., Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: Biochemical and diagnostic implications, CLIN CHEM, 46(1), 2000, pp. 47-54
Authors:
Jung, K
Elgeti, U
Lein, M
Brux, B
Sinha, P
Rudolph, B
Hauptmann, S
Schnorr, D
Loening, SA
Citation: K. Jung et al., Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: Which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?, CLIN CHEM, 46(1), 2000, pp. 55-62
Citation: M. Jung et al., Methods in molecular biology: minor errors in primer citations with major consequences: how can we minimize these mistakes?, BR J CANC, 82(9), 2000, pp. 1611-1612
Authors:
Friedrich, B
Jung, K
Lein, M
Turk, I
Rudolph, B
Hampel, G
Schnorr, D
Loening, SA
Citation: B. Friedrich et al., Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue, EUR J CANC, 35(1), 1999, pp. 138-144
Authors:
Jung, K
Brux, B
Lein, M
Knabich, A
Sinha, P
Rudolph, B
Schnorr, D
Loening, SA
Citation: K. Jung et al., Determination of alpha(1)-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA, UROLOGY, 53(6), 1999, pp. 1160-1167
Authors:
Jung, K
Brux, B
Lein, M
Sinha, P
Schnorr, D
Loening, SA
Citation: K. Jung et al., Determination of alpha(1)-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA - Reply, UROLOGY, 53(6), 1999, pp. 1168-1168
Authors:
Jung, K
Zachow, J
Lein, M
Brux, B
Sinha, P
Lenk, S
Schnorr, D
Loening, SA
Citation: K. Jung et al., Rapid detection of elevated prostate-specific antigen levels in blood: Performance of various membrane strip tests compared, UROLOGY, 53(1), 1999, pp. 155-160
Authors:
Fahlenkamp, D
Rassweiler, J
Fornara, P
Frede, T
Loening, SA
Citation: D. Fahlenkamp et al., Complications of laparoscopic procedures in urology: Experience with 2,407procedures at 4 German centers, J UROL, 162(3), 1999, pp. 765-770
Authors:
Lein, M
Jung, K
Brux, B
Knabich, A
Sinha, P
Schnorr, D
Loening, SA
Citation: M. Lein et al., Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: Studies in serum and plasma samples, J UROL, 162(2), 1999, pp. 502-502
Citation: Sa. Loening, Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates - Comment, J UROL, 161(3), 1999, pp. 804-804
Authors:
Jung, K
Brux, B
Knabich, A
Lein, M
Sinha, P
Schnorr, D
Loening, SA
Citation: K. Jung et al., A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha(1)-antichymotrypsin-prostate-specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasia, CLIN CHEM, 45(3), 1999, pp. 422-424